British company Corin Group PLC is confirming that the FDA Advisory Panel has recommended an FDA approval of Corin’s hip resurfacing device. Cormet system is another example of bone-sparing hip resurfacing devices, designed primarily for younger active patients with osteoarthritis or rheumatoid arthritis.
The company, about some of the perks of their device:
The third generation of advanced instrumentation for Cormet Hip Resurfacing allows small incision surgical approaches to be used for Cormet Hip Resurfacing. The Cormet Precision instruments eliminate the need for a complex, bulky head centering jig. The vacuum introducer is a unique, patented technology – standard theatre suction is used to attach the cup to the introducer for implantation of the acetabular component.
The Precision head centring device eliminates the need for a lateral pin and allows a smaller incision to be used in both standard and MIS approaches, reducing tissue damage and potentially improving post-operative recovery times. The instruments are simple to use, reducing operating time and allowing more accurate, reproducible placement of the femoral resurfacing component…
Exacting manufacturing techniques mean that the high carbon cobalt chrome bearing surfaces are optimised to minimise wear. Optimal sphericity, surface roughness and diametrical separation of the components result in enhanced lubrication of the bearing, which reduces wear, as well as providing effective function and longevity. Studies have shown that optimised sphericity and diametrical separation are by far the most important factors influencing the wear of metal-on-metal bearings.
This possible approval of the Cormet™ Hip Resurfacing System is stepping on the toes of Birmingham Hip, from Smith & Nephew, a device that we recently covered.
To learn more about Cormet™ Hip go here…
The press release…